Ypsomed Delivery Systems is a manufacturer of injection devices used to dispense medication in clinical trials. The company, headquartered in Switzerland, is a leader in the field with 30 years of experience developing and manufacturing injection and infusion systems.
Ypsomed sought to create a digital solution for medication adherence monitoring and smart device management for contract research organizations’ (CROs) use in clinical trials, including self-injection systems for trial participants to administer medications at home. Yet the company faced serious demands for remote device management, global scale, and privacy and security regulations such as HIPAA and GDPR.
To solve these challenges, Ypsomed adopted Philips’ HealthSuite digital platform (HSDP), a cloud platform built on Amazon Web Services (AWS). HSDP allows Ypsomed to connect devices to the cloud and remotely manage them, store data, and manage and scale services globally within healthcare regulatory, privacy, and security requirements.
Leveraging the power of the cloud, Ypsomed, Philips, and AWS are enhancing medication adherence in the clinical trials process.
In this case study, you'll learn how to
- Use connected self-injection devices to enhance patient adherence during clinical trials
- Leverage device-to-cloud connectivity, IoT, and data integrations that meet healthcare regulatory, privacy and security requirements to accelerate clinical trials
- Create “smart” solutions using Philips HealthSuite digital platform as a managed platform to consume AWS services including Amazon EC2, Amazon S3, and AWS Lambda
DOWNLOAD CASE STUDY
Date January 31, 2018
Time 1:00 PST/ 4:00 PM EST
AWS Partner Webinars
Attend live virtual sessions hosted by AWS and AWS Competency Partners on topics ranging from AI to Cloud Migration.
Modernizing Clinical Trials and Pharmacovigilance
See how AWS provides tools and services that can help you and your teams reduce time to clinical insights.